World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
71
Citations
16378
World Ranking
5620
National Ranking
1735

Michael R. Kilbourn publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Michael R. Kilbourn sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 296 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Michael R. Kilbourn D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Kilbourn sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 71 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Michael R. Kilbourn is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on the intersection of medicine, biochemistry, genetics, and molecular biology, with particular emphasis on radiology, nuclear medicine, and imaging.

The scientist has contributed extensively to in vivo medical imaging techniques and radiopharmaceutical chemistry, with a notable focus on neuroscience and neuropharmacology research. Their work also spans biotin-related studies, receptor mechanisms and signaling, and advanced MRI techniques.

Frequent coauthors in Kilbourn's research include Peter J. H. Scott, Allen F. Brooks, Alexandra Sowa, Xia Shao, and Tanpreet Kaur. These collaboration patterns suggest active engagement in interdisciplinary and team-based research efforts.

Publications by Michael R. Kilbourn have appeared in established venues such as ACS Chemical Neuroscience, Nuclear Medicine and Biology, EJNMMI Radiopharmacy and Chemistry, Biomedicines, and ACS Medicinal Chemistry Letters. The distribution of publications highlights a consistent presence in journals specializing in chemical neuroscience and nuclear medicine.

Representative recent papers include:

  • Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC), 2020, EJNMMI Radiopharmacy and Chemistry
  • 11C- and 18F-Radiotracers for In Vivo Imaging of the Dopamine System: Past, Present and Future, 2021, Biomedicines
  • Classics in Neuroimaging: Development of Positron Emission Tomography Tracers for Imaging the GABAergic Pathway, 2020, ACS Chemical Neuroscience
  • Classics in Neuroimaging: Shedding Light on Opioid Receptors with Positron Emission Tomography Imaging, 2020, ACS Chemical Neuroscience
  • Classics in Neuroimaging: Imaging the Cholinergic System with Positron Emission Tomography, 2021, ACS Chemical Neuroscience

Their work addresses major topics such as medical imaging techniques and applications, radiopharmaceutical chemistry, neuroscience and neuropharmacology, and lung cancer treatments and mutations, illustrating a broad application of molecular and cellular biology methodologies.

Best Publications

  • A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

    Mark A. Mintun;Marcus E. Raichle;Michael R. Kilbourn;G. Frederick Wooten

  • Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

    Jon-Kar Zubieta;Yolanda R. Smith;Joshua A. Bueller;Yanjun Xu

  • Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain

    Seok Rye Choi;Geoff Golding;Zhiping Zhuang;Wei Zhang

  • μ-Opioid Receptor-Mediated Antinociceptive Responses Differ in Men and Women

    Jon Kar Zubieta;Yolanda R. Smith;Joshua A. Bueller;Yanjun Xu

  • Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography

    R. A. Koeppe;V. A. Holthoff;K. A. Frey;K. A. Frey;M. R. Kilbourn

  • Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals.

    Douglas D. Dischino;Michael J. Welch;Michael R. Kilbourn;Marcus E. Raichle

  • Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

    Kirk A. Frey;Robert A. Koeppe;Michael R. Kilbourn;Thierry M. Vander Borght

  • Effects of Buprenorphine Maintenance Dose on μ -Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers

    Mark K. Greenwald;Chris Ellyn Johanson;David E. Moody;James H. Woods

  • Preparation of four fluorine- 18-labeled estrogens and their selective uptakes in target tissues of immature rats.

    Dale O. Kiesewetter;Michael R. Kilbourn;Scott W. Landvatter;Daniel F. Heiman

  • Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers

    Chris Ellyn Johanson;Kirk A. Frey;Leslie H. Lundahl;Pamela Keenan

  • Positron Emission Tomographic Measurement of Cerebral Blood Flow and Permeability—Surface Area Product of Water Using [15O]Water and [11C]Butanol

    Peter Herscovitch;Marcus E. Raichle;Michael R. Kilbourn;Michael J. Welch

  • Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: Improved synthesis of [18F]GBR‐13119

    Michael S. Haka;Michael R. Kilbourn;G. Leonard Watkins;Steven A. Toorongian

  • The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.

    Thierry Vander Borght;Michael Kilbourn;Timothy Desmond;David Kuhl

  • Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin.

    Steven A. Toorongian;G.Keith Mulholland;Douglas M. Jewett;Michael A. Bachelor

  • Increased ventral striatal monoaminergic innervation in Tourette syndrome.

    Roger L. Albin;R. A. Koeppe;N. I. Bohnen;T. E. Nichols

  • Strategies for in vivo measurement of receptor binding using positron emission tomography.

    Joel S. Perlmutter;Kenneth B. Larson;Marcus E. Raichle;Joanne Markham

  • Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue.

    Paul A. Jerabek;Timothy B. Patrick;Michael R. Kilbourn;Douglas D. Dischino

  • Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study

    Jon Kar Zubieta;Mark K. Greenwald;Umberto Lombardi;James H. Woods

  • Fluorine-18 Labeling of Proteins

    Michael R. Kilbourn;Carmen S. Dence;Michael J. Welch;Carla J. Mathias

  • A simple 18O water target for 18F production.

    Michael R. Kilbourn;John T. Hood;Michael J. Welch

  • Kinetic Modeling of N-[11C]Methylpiperidin-4-yl Propionate: Alternatives for Analysis of an Irreversible Positron Emission Tomography Tracer for Measurement of Acetylcholinesterase Activity in Human Brain:

    Robert A. Koeppe;Kirk A. Frey;Scott E. Snyder;Phillipp Meyer

  • The vesicular monoamine transporter is not regulated by dopaminergic drug treatment.

    Thierry Vander Borght;M.R. Kilbourn;T.J. Desmond;D.E. Kuhl

Frequent Co-Authors

Kirk A. Frey
Kirk A. Frey University of Michigan–Ann Arbor
Robert A. Koeppe
Robert A. Koeppe University of Michigan–Ann Arbor
Michael J. Welch
Michael J. Welch Washington University in St. Louis
David E. Kuhl
David E. Kuhl University of Michigan–Ann Arbor
Roger L. Albin
Roger L. Albin University of Michigan–Ann Arbor
John A. Katzenellenbogen
John A. Katzenellenbogen University of Illinois at Urbana-Champaign
Satoshi Minoshima
Satoshi Minoshima University of Utah
Marcus E. Raichle
Marcus E. Raichle Washington University in St. Louis
Nicolaas I. Bohnen
Nicolaas I. Bohnen University of Michigan–Ann Arbor
James H. Woods
James H. Woods University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their education beyond Chemistry, there are several related online degrees that offer diverse career opportunities. Understanding how much is criminal justice school can be crucial for budgeting if you’re considering a shift or addition to your academic path in fields like forensic chemistry or legal consulting.

Starting with an online associates in criminal justice can provide a foundational understanding for those interested in law enforcement or crime scene investigation careers, complementing Chemistry skills with legal and procedural knowledge.

Additionally, degrees for paralegals offer a pathway into the legal sector, where scientific expertise can be valuable for specialized roles in patent law or environmental regulations. Exploring degrees for paralegals highlights the variety of education options and potential salaries in this field.

For Chemistry graduates interested in the commercial side of science, becoming a pharmaceutical sales rep is a viable career path. Learning about pharmaceutical sales rep salary and career paths can help gauge the financial and professional benefits of this role.

Best Scientists Citing Michael R. Kilbourn

Trending Scientists

Recently Published Articles